1,856 followers
RT @FrontImmunol: New Research: Identification of Sorafenib as a Treatment for Type 1 Diabetes: Th1 cell activation is considered a key med…
RT @FrontImmunol: New Research: Identification of Sorafenib as a Treatment for Type 1 Diabetes: Th1 cell activation is considered a key med…
New Research: Identification of Sorafenib as a Treatment for Type 1 Diabetes: Th1 cell activation is considered a key mediator of the pathogenesis of type 1 diabetes. Targeting IL-12-induced Th1 cell differentiation seems to be an effective… https://t.co/H